Regulation and governance of multinational drug trials in stroke: Barriers and possibilities

International Journal of Stroke

Volumn 10, Issue 3, 2015, Pages 425-428

  Berge, Eivind ^a   Ford, Gary A ^b   Bath, Philip M W ^c   Stapf, Christian ^d   van der Worp, H Bart ^e   Demotes, Jacques ^f   Broderick, Joseph ^g   Al Shahi Salman, Rustam ^h   Lees, Kennedy R ⁱ   Arnold, Marcel ^j   Diez Tejedor, Exuperio ^j   Jatuzis, Dalius ^j   Kobayashi, Adam ^j   Kõrv, Janika ^j   Krieger, Derk ^j   Sandercock, Peter ^j   van der Worp, Bart ^j  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d HÔPITAL LARIBOISIÈRE   (France)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f European Clinical Research Infrastructures Network (ECRIN)   (France)

^g UNIVERSITY OF CINCINNATI   (United States)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j NONE

more..

Author keywords

Multinational research; Regulatory barriers; Stroke trials

Indexed keywords

ARTICLE; CENTRALIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG RESEARCH; DRUG SCREENING; GOOD CLINICAL PRACTICE; HUMAN; LAW; ONLINE MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; RESEARCH ETHICS; STANDARD; CLINICAL TRIAL (TOPIC); ETHICS; INTERNATIONAL COOPERATION; LEGISLATION AND JURISPRUDENCE; MEDICAL RESEARCH; PROCEDURES; STROKE;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; INTERNATIONAL COOPERATION; STROKE;

EID: 84924902423     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12427     Document Type: Article

References (22)

1. European Commission. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Union 2001; L121-34-121201044.
2. The Academy of Medical Sciences. A new pathway for the regulation and governance of health research. 2011. Available at http://www.acmedsci.ac.uk/publications/ (accessed 16 December 2014).
3. Al-Shahi Salman R, Beller E, Kagan J etal. Increasing value and reducing waste in biomedical research regulation and management. Lancet 2014; 383:176-185.
4. Beecher HK. Ethics and clinical research. N Engl J Med 1966; 274:1354-1360.
5. Katz J. The nuremberg code and the nuremberg trial. A reappraisal. JAMA 1996; 276:1662-1666.
6. European Forum for Good Clinical Practice (EFGCP). Impact on clinical research of European legislation (ICREL). 2009. Available at http://www.efgcp.be/icrel/ (accessed 16 December 2014).
7. Organisation for Economic Co-operation and Development (OECD) Global Science Forum. OECD Recommendation on the governance of clinical trials. 2013.
8. Christie DR, Gabriel GS, Dear K. Adverse effects of a multicentre system for ethics approval on the progress of a prospective multicentre trial of cancer treatment: how many patients die waiting? Intern Med J 2007; 37:680-686.
9. Hansson MG. Need for a wider view of autonomy in epidemiological research. BMJ 2010; 340:c2335.
10. Duley L, Antman K, Arena J etal. Specific barriers to the conduct of randomized trials. Clin Trials 2008; 5:40-48.
11. Reith C, Landray M, Devereaux PJ etal. Randomized clinical trials - removing unnecessary obstacles. N Engl J Med 2013; 369:1061-1065.
12. Hesse K, Fulton RL, Abdul-Rahim AH, Lees KR. Characteristic adverse events and their incidence among patients participating in acute ischemic stroke trials. Stroke 2014; 45:2677-2682.
13. Blunt J, Savulescu J, Watson AJ. Meeting the challenges facing research ethics committees: some practical suggestions. BMJ 1998; 316:58-61.
14. Medicines and Healthcare Products Regulatory Agency. Risk-adapted approaches to the management of clinical trials of investigational medicinal products. 2012. Available at http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectionandstandards/GoodClinicalPractice/News/CON126145 (accessed 16 December 2014).
15. The European Parliament and the Council of the European Union. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. Off J Eur Union 2014; 57:L58-1-5820176.
16. Westra AE, Bos W, Cohen AF. New EU clinical trials regulation. BMJ 2014; 348:g3710.
17. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003; 290:1624-1632.
18. Department of Health (Research and Development Directorate). Best Strategy for Best Health: A New National Health Research Strategy. London, Department of Health, 2006.
19. UK Stroke Research Network. Available at http://www.invo.org.uk/find-out-more/invodirect-org/the-nihr-stroke-research-network/ (accessed 16 December 2014).
20. European Clinical Research Infrastructure Network (ECRIN). Available at http://www.ecrin.org/ (accessed 16 December 2014).
21. European Stroke Organisation (ESO) Trials Network Committee. Available at http://www.eso-stroke.org/eso-stroke/abouteso/committees.html (accessed 16 December 2014).
22. Broderick JP, Jauch EC, Derdeyn CP. American Stroke Association Stroke Council update. Stroke 2014; 45:e5-7.